Acute leukemia (AL) is a hematologic neoplasm characterized by excessive proliferation of undifferentiated blast cells in the bone marrow and peripheral blood. Understanding the relationship between laboratory and clinical manifestations of the disease is crucial for assessing prognosis, selecting treatment strategies, and evaluating therapeutic response. This article analyzes the clinical significance of hematologic parameters, immunophenotypic markers, cytogenetic, and molecular alterations in patients with AL, based on scientific studies published between 2020 and 2025.

acute leukemia, blasts, leukemia, thrombocytopenia, anemia

Chadha R, Udayakumar DS, Sangwan S, Gore A, Jha B, Goel S, et al. Cytogenetic risk stratification of B-acute lymphoblastic leukemia and its correlation with other prognostic factors. Int J Lab Hematol. 2023;45(2):287–296.

Papaemmanuil E, Gerstung M, Bullinger L, Gaidzik VI, Paschka P, Roberts ND, et al. Genomic classification and prognosis in acute myeloid leukemia. N Engl J Med. 2022;386(1):44–59. doi:10.1056/NEJMoa1516192.

Rasool M, Farooq S, Malik A, Shaukat A, Manan A, Asif M, Sani S, Qazi MH, Kamal MA, Iqbal Z, Hussain A. Assessment of circulating biochemical markers and antioxidative status in acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) patients. Saudi J Biol Sci. 2015;22(1):106–111. doi:10.1016/j.sjbs.2014.09.002.

Şenol HB, Gürocak ÖT, Yılmaz Ş, Ören H. Clinical and laboratory characteristics of children with leukemia: a 34-year single-center experience. J Pediatr Hematol Oncol. 2022;44(3):145–152.

Shahgholi E, Sadatinejad SM, Yazdi MK. The relationship between early clinical presentation, laboratory data, and minimal residual disease of acute lymphoblastic leukemia with cytogenetic findings in children. J Pediatr Hematol Oncol. 2022;44(3):155–164.

Shimony S, Stahl M, Stone RM. Acute myeloid leukemia: 2025 update on diagnosis, risk-stratification, and management. Blood Rev. 2025;59:101013. doi:10.1016/j.blre.2025.101013.

Singh D, Agarwal R. Correlation between hematological parameters and disease severity in acute leukemia patients. J Hematol Clin Res. 2021;5(3):102–108.

Soliman ASM, Osman AA, Diaa El-Dine DA. Evaluation of CD96 expression in acute myeloid leukemia patients: relation to prognosis and induction chemotherapy. QJM: An International Journal of Medicine. 2024;117(Suppl_2):hcae175.180.

Tripathi AK, Chuda R. Laboratory evaluation of acute leukemia. University of Kansas Medical Center. Updated January 5, 2025.

Xiao Z, Gong R, Chen X, Xiao D, Luo S, Ji Y. Association between serum lactate dehydrogenase and 60-day mortality in Chinese Hakka patients with acute myeloid leukemia: a cohort study. J Clin Lab Anal. 2021;35(12):e24049. doi:10.1002/jcla.24049.